HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoko Morishima Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

10/2020R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
3/2017The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
11/2015Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
12/2014A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy.
3/2013Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience.
10/2012Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoko Morishima Research Topics

Disease

18Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 05/2004
10Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2023 - 10/2017
8Leukemia
01/2023 - 08/2013
6Neoplasms (Cancer)
02/2024 - 02/2007
6Lymphoma (Lymphomas)
01/2023 - 10/2012
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2020 - 10/2012
4Hematologic Neoplasms (Hematological Malignancy)
05/2022 - 08/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 07/2015
2T-Cell Leukemia (Leukemia, T Cell)
11/2023 - 01/2019
2Autoimmune Diseases (Autoimmune Disease)
01/2023 - 01/2016
1Anastomotic Leak
02/2023
1Hemorrhage
02/2023
1Hepatocellular Carcinoma (Hepatoma)
02/2023
1Exanthema (Rash)
01/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Melanoma (Melanoma, Malignant)
01/2023
1Amyopathic dermatomyositis
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Philadelphia Chromosome
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021
1Bronchiolitis Obliterans Syndrome
01/2021
1Inflammation (Inflammations)
01/2020
1Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2019
1Radiodermatitis
02/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Insulin Resistance
01/2019
1Liver Diseases (Liver Disease)
01/2019
1Rheumatoid Arthritis
01/2018
1Graves Disease (Basedow Disease)
01/2016
1Hashimoto Disease (Thyroiditis, Hashimoto)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2014

Drug/Important Bio-Agent (IBA)

5HLA-A Antigens (HLA-A)IBA
11/2022 - 02/2007
5HLA-DPB1 antigen (HLA DPB1)IBA
11/2021 - 02/2015
4Rituximab (Mabthera)FDA Link
01/2023 - 10/2012
4HLA Antigens (Human Leukocyte Antigens)IBA
11/2022 - 01/2018
3KIR ReceptorsIBA
01/2022 - 01/2021
3LigandsIBA
01/2022 - 01/2021
3RNA (Ribonucleic Acid)IBA
12/2021 - 03/2017
3DNA (Deoxyribonucleic Acid)IBA
03/2017 - 11/2015
2HLA-DRB1 Chains (HLA DRB1)IBA
01/2022 - 01/2018
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 12/2021
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2022 - 12/2021
2Xanthine OxidaseIBA
10/2019 - 01/2019
2HLA-C Antigens (HLA-C)IBA
04/2016 - 02/2015
2Immunoglobulin G (IgG)IBA
12/2014 - 10/2012
2AntigensIBA
03/2008 - 08/2007
1ChromatinIBA
02/2024
1atezolizumabIBA
02/2023
1Blood Coagulation Factors (Coagulation Factor)IBA
02/2023
1Factor V (Coagulation Factor V)IBA
02/2023
1Immune Checkpoint InhibitorsIBA
02/2023
1Bevacizumab (Avastin)FDA Link
02/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023
1IsoantibodiesIBA
01/2023
1AutoantibodiesIBA
01/2023
1Messenger RNA (mRNA)IBA
05/2022
1Adenosine Triphosphate (ATP)IBA
05/2022
1Glucose (Dextrose)FDA LinkGeneric
05/2022
11,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
05/2022
1NADP (NADPH)IBA
05/2022
1Sodium-Glucose Transport ProteinsIBA
05/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
05/2022
1Calcineurin InhibitorsIBA
01/2022
1HLA-G Antigens (HLA G)IBA
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
12/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2021
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2021
1ChemokinesIBA
01/2020
1CytokinesIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
09/2019
1mogamulizumabIBA
02/2019
1Ointments (Pastes)IBA
02/2019
1Transaminases (Aminotransferases)IBA
01/2019
1Uric Acid (Urate)IBA
01/2019
1NucleotidesIBA
01/2018
1Interleukin-2 Receptors (IL 2 Receptor)IBA
10/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2017
1CalciumIBA
10/2017
1HLA-B Antigens (HLA-B)IBA
04/2016
1Chemokine CXCL12IBA
03/2016
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2016
1Transcription Factors (Transcription Factor)IBA
03/2016
1Neutralizing AntibodiesIBA
12/2014

Therapy/Procedure

12Hematopoietic Stem Cell Transplantation
11/2023 - 03/2008
9Transplantation
01/2023 - 08/2013
5Therapeutics
02/2024 - 04/2016
5Stem Cell Transplantation
01/2023 - 12/2015
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2022 - 05/2004
4Drug Therapy (Chemotherapy)
10/2020 - 10/2012
2Cell Transplantation
12/2021 - 08/2013
2Induction Chemotherapy
10/2020 - 07/2015
2Radiotherapy
02/2019 - 01/2019
2Immunotherapy
08/2007 - 02/2007
1Hepatectomy
02/2023
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2021
1Autologous Transplantation
10/2020
1Donor Selection
04/2016